bioon.com 生物谷
生物谷RSS 生物谷手机WAP浏览支持
专业平台生物 | 产业 | 药学 | 医学 | 视频 | 实验 | 健康 | 图谱 | 考试 | 招聘 | 社区 | VIP | English
企业服务企业平台 | 产品大全 | 供求信息 | 名企展厅 | 会议会展 | 黄页 | 广告 | 服务 | 生意通 | E-solution
个人服务彩信 | 继续教育 | 博客 | 书库 | 资料 | 竞拍 | 求职 | 网址导航 | 下载 | 论坛 | 投稿 | TILS
您现在的位置: 生物谷 >> 实验 >> DNA实验 >> 质粒信息数据库 >> 实验频道正文
rss

质粒pLP-EGFP-C1信息

Vector Map

Map of pLP-EGFP-C1 Vector. Unique restriction sites are shown in bold.

Note: The vector sequence file has been compiled from information in the sequence database, published literature, and other sources, together with partial sequences obtained by CLONTECH. This vector has not been completely sequenced.

pLP-EGFP-C1 Acceptor Vector is designed to be used with CLONTECH's Creator™ Cloning Kits to rapidly generate a reporter construct expressing a fusion between the protein of interest and enhanced green fluorescent protein (EGFP). Instead of a multiple cloning site (MCS), pLP-EGFP-C1 contains the loxP sequence from the P1 bacteriophage (1). In the presence of Cre Recombinase, the loxP site allows rapid transfer of a gene of interest from any Creator System donor vector into pLP-EGFP-C1 through Cre-mediated recombination (1). Genes cloned into the donor vector in frame with the loxP site will automatically be in frame with EGFP when transferred to pLP-EGFP-C1. The target gene should be cloned into the donor vector so that it is in frame with the upstream loxP site with no intervening in-frame stop codons.

The gene of interest is expressed from the immediate early promoter of cytomegalovirus (PCMV IE) as a C-terminal fusion to EGFP. EGFP is a red-shifted variant of wild-type GFP (2–4), which has been optimized for brighter fluorescence and higher expression in mammalian cells. (Excitation maximum = 488 nm; emission maximum = 507 nm.) SV40 polyadenylation signals downstream of the EGFP gene direct proper processing of the 3' end of the EGFP mRNA. The pLP-EGFP-C1 backbone also contains an SV40 origin for replication in mammalian cells expressing the SV40 T-antigen. A neomycin resistance cassette (Neor), consisting of the SV40 early promoter, the neomycin/kanamycin resistance gene of Tn5, and polyadenylation signals from the Herpes simplex virus thymidine kinase (HSV TK) gene, allows stably transfected eukaryotic cells to be selected using G418 (5). A bacterial promoter upstream of this cassette expresses kanamycin resistance in E. coli. The vector backbone also provides a pUC origin of replication for propagation in E. coli and an f1 origin for single-stranded DNA production.

pLP-EGFP-C1 also contains a bacterial promoter adjacent to the loxP site. This promoter drives expression of the chloramphenicol resistance gene, which is transferred from the donor vector in conjunction with the gene of interest. The separation of the promoter and the coding sequence on the two parent vectors (pLP-EGFP-C1 and the donor vector), ensures that only recombinant pLP-EGFP-C1 vectors containing the transferred fragment in the correct orientation will be propagated in the presence of chloramphenicol. The inclusion of sucrose in the medium provides further selection against the parent donor vector.

Use

The EGFP fusion protein expressed from pLP-EGFP-C1 can be used to monitor gene expression and protein localization for the gene of interest. Fusions to the C terminus of EGFP retain the fluorescent properties of the native protein allowing the localization of the fusion protein in vivo. The recombinant EGFP vector can be transfected into mammalian cells using any standard transfection method. If required, stable transformants can be selected using G418 (5). pLP-EGFP-C1 can also be used simply to express EGFP in a cell line of interest (e.g., as a transfection marker).

Location of Features

  • Human cytomegalovirus (CMV) immediate early promoter: 1–589
      Enhancer region: 59–465; TATA box: 554–560
      Transcription start point: 583
      C->G mutation to remove Sac I site: 569
  • Enhanced green fluorescent protein gene
      Start codon (ATG): 613–615; Stop codon: 1408–1410
      Insertion of Val at position 2: 616–618
      GFPmut1 chromophore mutations (Phe-64 to Leu; Ser-65 to Thr): 805–810
      His-231 to Leu mutation (AÆT): 1307
      Last amino acid in wild-type GFP: 1327–1329
  • loxP site: 1360–1393
  • Bacterial promoter: 1394–1520
  • SV40 early mRNA polyadenylation signal
      Polyadenylation signals: 1681–1686 &1710 –1715; mRNA 3' ends: 1719 & 1731
  • f1 single-strand DNA origin: 1778–2233 (Packages the noncoding strand of EGFP.)
  • Bacterial promoter for expression of Kanr gene
      –35 region: 2295–2300; –10 region: 2318–2322
      Transcription start point: 2330
  • SV40 origin of replication: 2574–2709
  • SV40 early promoter
      Enhancer (72-bp tandem repeats): 2407–2478 & 2479–2550
      21-bp repeats: 2554–2574, 2575–2595, & 2597–2617
      Early promoter element: 2630–2636
      Major transcription start points: 2626, 2664, 2670 & 2675
  • Kanamycin/neomycin resistance gene
      Neomycin phosphotransferase coding sequences:
      Start codon (ATG): 2758–2760; stop codon: 3550–3552
      G->A mutation to remove Pst I site: 2940
      C->A (Arg to Ser) mutation to remove BssH II site: 3286
  • Herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signal
      Polyadenylation signals: 3788–3793 & 3801–3806
  • pUC plasmid replication origin: 4137–4780

Primer Locations

  • EGFP-N Sequencing Primer (#6479-1): 679–658
  • EGFP-C Sequencing Primer (#6478-1): 1266–1287
  • 全序列:

    TAGTTATTAA TAGTAATCAA TTACGGGGTC ATTAGTTCAT AGCCCATATA TGGAGTTCCG
    CGTTACATAA CTTACGGTAA ATGGCCCGCC TGGCTGACCG CCCAACGACC CCCGCCCATT
    GACGTCAATA ATGACGTATG TTCCCATAGT AACGCCAATA GGGACTTTCC ATTGACGTCA
    ATGGGTGGAG TATTTACGGT AAACTGCCCA CTTGGCAGTA CATCAAGTGT ATCATATGCC
    AAGTACGCCC CCTATTGACG TCAATGACGG TAAATGGCCC GCCTGGCATT ATGCCCAGTA
    CATGACCTTA TGGGACTTTC CTACTTGGCA GTACATCTAC GTATTAGTCA TCGCTATTAC
    CATGGTGATG CGGTTTTGGC AGTACATCAA TGGGCGTGGA TAGCGGTTTG ACTCACGGGG
    ATTTCCAAGT CTCCACCCCA TTGACGTCAA TGGGAGTTTG TTTTGGCACC AAAATCAACG
    GGACTTTCCA AAATGTCGTA ACAACTCCGC CCCATTGACG CAAATGGGCG GTAGGCGTGT
    ACGGTGGGAG GTCTATATAA GCAGAGCTGG TTTAGTGAAC CGTCAGATCC GCTAGCGCTA
    CCGGTCGCCA CCATGGTGAG CAAGGGCGAG GAGCTGTTCA CCGGGGTGGT GCCCATCCTG
    GTCGAGCTGG ACGGCGACGT AAACGGCCAC AAGTTCAGCG TGTCCGGCGA GGGCGAGGGC
    GATGCCACCT ACGGCAAGCT GACCCTGAAG TTCATCTGCA CCACCGGCAA GCTGCCCGTG
    CCCTGGCCCA CCCTCGTGAC CACCCTGACC TACGGCGTGC AGTGCTTCAG CCGCTACCCC
    GACCACATGA AGCAGCACGA CTTCTTCAAG TCCGCCATGC CCGAAGGCTA CGTCCAGGAG
    CGCACCATCT TCTTCAAGGA CGACGGCAAC TACAAGACCC GCGCCGAGGT GAAGTTCGAG
    GGCGACACCC TGGTGAACCG CATCGAGCTG AAGGGCATCG ACTTCAAGGA GGACGGCAAC
    ATCCTGGGGC ACAAGCTGGA GTACAACTAC AACAGCCACA ACGTCTATAT CATGGCCGAC
    AAGCAGAAGA ACGGCATCAA GGTGAACTTC AAGATCCGCC ACAACATCGA GGACGGCAGC
    GTGCAGCTCG CCGACCACTA CCAGCAGAAC ACCCCCATCG GCGACGGCCC CGTGCTGCTG
    CCCGACAACC ACTACCTGAG CACCCAGTCC GCCCTGAGCA AAGACCCCAA CGAGAAGCGC
    GATCACATGG TCCTGCTGGA GTTCGTGACC GCCGCCGGGA TCACTCTCGG CATGGACGAG
    CTGTACAAGT CCGGACTCAG ATCTCGAGCT CAAGCTTCGA TAACTTCGTA TAGCATACAT
    TATACGAAGT TATAGATCCA ATATTATTGA AGCATTTATC AGGGTTATTG TCTCATGAGC
    GGATACATAT TTGAATGTAT TTAGAAAAAT AAACAAATAG GGGTTCCGCG CACATTTCCC
    CGAAAAGTGC CACCTGACGT GGATCCACCG GATCTAGATA ACTGATCATA ATCAGCCATA
    CCACATTTGT AGAGGTTTTA CTTGCTTTAA AAAACCTCCC ACACCTCCCC CTGAACCTGA
    AACATAAAAT GAATGCAATT GTTGTTGTTA ACTTGTTTAT TGCAGCTTAT AATGGTTACA
    AATAAAGCAA TAGCATCACA AATTTCACAA ATAAAGCATT TTTTTCACTG CATTCTAGTT
    GTGGTTTGTC CAAACTCATC AATGTATCTT AACGCGTAAA TTGTAAGCGT TAATATTTTG
    TTAAAATTCG CGTTAAATTT TTGTTAAATC AGCTCATTTT TTAACCAATA GGCCGAAATC
    GGCAAAATCC CTTATAAATC AAAAGAATAG ACCGAGATAG GGTTGAGTGT TGTTCCAGTT
    TGGAACAAGA GTCCACTATT AAAGAACGTG GACTCCAACG TCAAAGGGCG AAAAACCGTC
    TATCAGGGCG ATGGCCCACT ACGTGAACCA TCACCCTAAT CAAGTTTTTT GGGGTCGAGG
    TGCCGTAAAG CACTAAATCG GAACCCTAAA GGGAGCCCCC GATTTAGAGC TTGACGGGGA
    AAGCCGGCGA ACGTGGCGAG AAAGGAAGGG AAGAAAGCGA AAGGAGCGGG CGCTAGGGCG
    CTGGCAAGTG TAGCGGTCAC GCTGCGCGTA ACCACCACAC CCGCCGCGCT TAATGCGCCG
    CTACAGGGCG CGTCAGGTGG CACTTTTCGG GGAAATGTGC GCGGAACCCC TATTTGTTTA
    TTTTTCTAAA TACATTCAAA TATGTATCCG CTCATGAGAC AATAACCCTG ATAAATGCTT
    CAATAATATT GAAAAAGGAA GAGTCCTGAG GCGGAAAGAA CCAGCTGTGG AATGTGTGTC
    AGTTAGGGTG TGGAAAGTCC CCAGGCTCCC CAGCAGGCAG AAGTATGCAA AGCATGCATC
    TCAATTAGTC AGCAACCAGG TGTGGAAAGT CCCCAGGCTC CCCAGCAGGC AGAAGTATGC
    AAAGCATGCA TCTCAATTAG TCAGCAACCA TAGTCCCGCC CCTAACTCCG CCCATCCCGC
    CCCTAACTCC GCCCAGTTCC GCCCATTCTC CGCCCCATGG CTGACTAATT TTTTTTATTT
    ATGCAGAGGC CGAGGCCGCC TCGGCCTCTG AGCTATTCCA GAAGTAGTGA GGAGGCTTTT
    TTGGAGGCCT AGGCTTTTGC AAAGATCGAT CAAGAGACAG GATGAGGATC GTTTCGCATG
    ATTGAACAAG ATGGATTGCA CGCAGGTTCT CCGGCCGCTT GGGTGGAGAG GCTATTCGGC
    TATGACTGGG CACAACAGAC AATCGGCTGC TCTGATGCCG CCGTGTTCCG GCTGTCAGCG
    CAGGGGCGCC CGGTTCTTTT TGTCAAGACC GACCTGTCCG GTGCCCTGAA TGAACTGCAA
    GACGAGGCAG CGCGGCTATC GTGGCTGGCC ACGACGGGCG TTCCTTGCGC AGCTGTGCTC
    GACGTTGTCA CTGAAGCGGG AAGGGACTGG CTGCTATTGG GCGAAGTGCC GGGGCAGGAT
    CTCCTGTCAT CTCACCTTGC TCCTGCCGAG AAAGTATCCA TCATGGCTGA TGCAATGCGG
    CGGCTGCATA CGCTTGATCC GGCTACCTGC CCATTCGACC ACCAAGCGAA ACATCGCATC
    GAGCGAGCAC GTACTCGGAT GGAAGCCGGT CTTGTCGATC AGGATGATCT GGACGAAGAG
    CATCAGGGGC TCGCGCCAGC CGAACTGTTC GCCAGGCTCA AGGCGAGCAT GCCCGACGGC
    GAGGATCTCG TCGTGACCCA TGGCGATGCC TGCTTGCCGA ATATCATGGT GGAAAATGGC
    CGCTTTTCTG GATTCATCGA CTGTGGCCGG CTGGGTGTGG CGGACCGCTA TCAGGACATA
    GCGTTGGCTA CCCGTGATAT TGCTGAAGAG CTTGGCGGCG AATGGGCTGA CCGCTTCCTC
    GTGCTTTACG GTATCGCCGC TCCCGATTCG CAGCGCATCG CCTTCTATCG CCTTCTTGAC
    GAGTTCTTCT GAGCGGGACT CTGGGGTTCG AAATGACCGA CCAAGCGACG CCCAACCTGC
    CATCACGAGA TTTCGATTCC ACCGCCGCCT TCTATGAAAG GTTGGGCTTC GGAATCGTTT
    TCCGGGACGC CGGCTGGATG ATCCTCCAGC GCGGGGATCT CATGCTGGAG TTCTTCGCCC
    ACCCTAGGGG GAGGCTAACT GAAACACGGA AGGAGACAAT ACCGGAAGGA ACCCGCGCTA
    TGACGGCAAT AAAAAGACAG AATAAAACGC ACGGTGTTGG GTCGTTTGTT CATAAACGCG
    GGGTTCGGTC CCAGGGCTGG CACTCTGTCG ATACCCCACC GAGACCCCAT TGGGGCCAAT
    ACGCCCGCGT TTCTTCCTTT TCCCCACCCC ACCCCCCAAG TTCGGGTGAA GGCCCAGGGC
    TCGCAGCCAA CGTCGGGGCG GCAGGCCCTG CCATAGCCTC AGGTTACTCA TATATACTTT
    AGATTGATTT AAAACTTCAT TTTTAATTTA AAAGGATCTA GGTGAAGATC CTTTTTGATA
    ATCTCATGAC CAAAATCCCT TAACGTGAGT TTTCGTTCCA CTGAGCGTCA GACCCCGTAG
    AAAAGATCAA AGGATCTTCT TGAGATCCTT TTTTTCTGCG CGTAATCTGC TGCTTGCAAA
    CAAAAAAACC ACCGCTACCA GCGGTGGTTT GTTTGCCGGA TCAAGAGCTA CCAACTCTTT
    TTCCGAAGGT AACTGGCTTC AGCAGAGCGC AGATACCAAA TACTGTCCTT CTAGTGTAGC
    CGTAGTTAGG CCACCACTTC AAGAACTCTG TAGCACCGCC TACATACCTC GCTCTGCTAA
    TCCTGTTACC AGTGGCTGCT GCCAGTGGCG ATAAGTCGTG TCTTACCGGG TTGGACTCAA
    GACGATAGTT ACCGGATAAG GCGCAGCGGT CGGGCTGAAC GGGGGGTTCG TGCACACAGC
    CCAGCTTGGA GCGAACGACC TACACCGAAC TGAGATACCT ACAGCGTGAG CTATGAGAAA
    GCGCCACGCT TCCCGAAGGG AGAAAGGCGG ACAGGTATCC GGTAAGCGGC AGGGTCGGAA
    CAGGAGAGCG CACGAGGGAG CTTCCAGGGG GAAACGCCTG GTATCTTTAT AGTCCTGTCG
    GGTTTCGCCA CCTCTGACTT GAGCGTCGAT TTTTGTGATG CTCGTCAGGG GGGCGGAGCC
    TATGGAAAAA CGCCAGCAAC GCGGCCTTTT TACGGTTCCT GGCCTTTTGC TGGCCTTTTG
    CTCACATGTT CTTTCCTGCG TTATCCCCTG ATTCTGTGGA TAACCGTATT ACCGCCATGC
    AT
    实验频道录入:admin    责任编辑:admin 


    评论】【收藏】【告诉好友】【打印】 【返回顶部】 【直达首页】 【进入论坛】 【转入博客】  

    文章评论(评论内容只代表网友观点,与生物谷立场无关!

    关于我们 | 广告服务 | 联系方式 | 帮助信息 | 服务条款 | 法律声明 | 战略伙伴 | 友情链接 | 生意通 | 网站地图 | Bioon English
    Copyright © 2001-2007 生物谷 bioon.com , All Rights Reserved. 版权所有
    不良信息举报信箱:editor#bioon.com
    网站备案:沪ICP备05022939号